Curetis to Launch CE-IVD Unyvero Blood Culture Application Cartridge at ECCMID 2016 – Successful completion of CE Performance Evaluation Study – Covers 103 diagnostic targets with […]

Curetis Validating Blood Culture Cartridge for CE-IVD Launch in Q2 Mar 03, 2016 NEW YORK (GenomeWeb) – In preparation for a CE-IVD launch in the second […]

Curetis Starts Final Validation Study for New Unyvero Blood Culture Application Cartridge – Data and CE-IVD launch expected in Q2, 2016 – Company also prepares launch […]

Curetis Expands Commercial Team – Company hires Willem Haagmans as Head of Sales EMEA – Amsterdam, the Netherlands and Holzgerlingen, Germany, February 3, 2016 — Curetis […]

Curetis Establishes Medical Advisory Board with Internationally Renowned Experts Curetis AG, 11 Jan 16,  Amsterdam, The Netherlands, and Holzgerlingen, Germany, January 11, 2016 – Curetis N.V., a […]

Epigenomics Receives FDA Notification About Status of Pending Approval Decision for Epi proColon® Berlin, Germany, January 8, 2016 – Epigenomics AG, Berlin, Germany, (Frankfurt Prime Standard: […]

Curetis AG / Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million .  Holzgerlingen, Germany, November 10, 2015 — Curetis N.V.[1] (the “Company” […]

http://www.epigenomics.com/en/news-investors/news-media/press-releases/latest-news/article/epigenomics-ag-gibt-ein-update-ueber-bluttests-zur-krebsfrueherkennung-auf-der-jahrestagung-2015-der.html